Side effects include:
Most adverse effects are manifestations of pharmacologic effects at muscarinic-cholinergic receptors and usually are reversible when therapy is discontinued. 
Severity and frequency of adverse effects are dose related and individual intolerance varies greatly; although adverse effects occasionally may be obviated by a reduction in dosage, this also will likely eliminate potential therapeutic effects.   If dosage of â‰¥80 mg daily cannnot be achieved because of intolerance, discontinue dicyclomine (the active ingredient contained in Bentyl)   
Dry mouth, dizziness, blurred vision, nausea, light-headedness (especially with the injectable form), drowsiness, weakness, nervousness. 
-The most serious adverse reactions include cardiovascular and central nervous system symptoms.-The most common adverse reactions are dizziness, dry mouth, vision blurred, nausea, somnolence, asthenia and nervousness, fever, tachycardia, agitation, and dry skin/mucous membranes.
Very common (10% or more): Dry mouth (33%), nausea (14%)Rare (less than 0.1%): Constipation, anorexiaFrequency not reported: Thirst, delayed gastric emptying time, reduced gastric acid secretion, gastroesophageal refluxPostmarketing reports: Abdominal distension, abdominal pain, dyspepsia, constipation, dry mouth, nausea, vomiting
Very common (10% or more): Dizziness (40%)Common (1% to 10%): Somnolence, nervousnessRare (less than 0.1%): Sedation, headachePostmarketing reports: Dizziness, headache, somnolence, syncope
Very common (10% or more): Blurred vision (27%)Frequency not reported: Follicular conjunctivitis, all muscarinic antagonists can precipitate glaucomaPostmarketing reports: Cycloplegia, mydriasis, blurred vision
Common (1% to 10%): AstheniaFrequency not reported: FatiguePostmarketing reports: Malaise, fatigue
Rare (less than 0.1%): RashPostmarketing reports: Allergic dermatitis, erythema, rash
Rare (less than 0.1%): Dysuria
Frequency not reported: Urinary retention, impotence in male patientsPostmarketing reports: Suppressed lactation
Postmarketing reports: Palpitations, tachyarrhythmias, thrombosis, thrombophlebitis
Postmarketing reports: Face edema, angioedema, anaphylactic shock
Postmarketing reports: Local pain, edema, skin color change, reflex sympathetic dystrophy syndrome (caused by inadvertent IV injection)
Postmarketing reports: Delirium or symptoms of delirium such as amnesia (or transient global amnesia), nervousness, agitation, confusional state, delusion, disorientation, hallucination (including visual hallucination), and mania, mood (altered and pseudodementia).
Postmarketing reports: Dyspnea, nasal congestion